Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Morice

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|July 5, 2005
Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertensionA H Morice, S Mulrennan, A Clark
Respiration; International Review of Thoracic Diseases|June 27, 2000
Comparison of the effect on bronchial hyperresponsiveness of beclomethasone dipropionate administered via a novel multidose dry-powder inhaler or a conventional pressurised metered dose inhalerA H Morice, B Andrews, M Taylor
Respiratory Physiology & Neurobiology|January 13, 2006
Clinical cough and its mechanismsL P A McGarvey, A H Morice
International Journal of Cardiology|January 28, 2009
Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentanS Faruqi, H Fathi, A H Morice
Thorax|August 29, 2006
Recommendations for the management of cough in adultsA H Morice, L McGarvey, I Pavord, et al.
Pulmonary Pharmacology & Therapeutics|January 27, 1999
The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertensionW Sheedy, S Haleen, A H Morice
The European Respiratory Journal|June 13, 2001
Sputum induction in young cystic fibrosis patientsJ A Kastelik, I Aziz, A H Morice
Thorax|March 14, 2001
Montelukast sodium in cystic fibrosisA H Morice, J A Kastelik, I Aziz
Respiratory Medicine|August 28, 1999
Cough induced by low pHC H Wong, R Matai, A H Morice
Lancet (London, England)|May 31, 1997
A malicious mouldC Bates, R C Read, A H Morice
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|July 5, 2005
Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertensionA H Morice, S Mulrennan, A Clark
Respiration; International Review of Thoracic Diseases|June 27, 2000
Comparison of the effect on bronchial hyperresponsiveness of beclomethasone dipropionate administered via a novel multidose dry-powder inhaler or a conventional pressurised metered dose inhalerA H Morice, B Andrews, M Taylor
Respiratory Physiology & Neurobiology|January 13, 2006
Clinical cough and its mechanismsL P A McGarvey, A H Morice
International Journal of Cardiology|January 28, 2009
Combination of sitaxentan and tadalafil for idiopathic pulmonary arterial hypertension following relapse on bosentanS Faruqi, H Fathi, A H Morice
Thorax|August 29, 2006
Recommendations for the management of cough in adultsA H Morice, L McGarvey, I Pavord, et al.
Pulmonary Pharmacology & Therapeutics|January 27, 1999
The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertensionW Sheedy, S Haleen, A H Morice
The European Respiratory Journal|June 13, 2001
Sputum induction in young cystic fibrosis patientsJ A Kastelik, I Aziz, A H Morice
Thorax|March 14, 2001
Montelukast sodium in cystic fibrosisA H Morice, J A Kastelik, I Aziz
Respiratory Medicine|August 28, 1999
Cough induced by low pHC H Wong, R Matai, A H Morice
Lancet (London, England)|May 31, 1997
A malicious mouldC Bates, R C Read, A H Morice
Pageof 15